Asia Deal Watch: LG Chem Calls On LabGenius’s AI Capabilities For Multispecific Antibodies Scrip Pharma Intelligence 22:08 Thu, 18 Jun
LG Chem taps AI-powered LabGenius platform to accelerate cancer drug discovery Korea Biomedical Review 03:23 Thu, 18 Jun
LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/Ml-Designed Tumour-Targeting Antibody Business Wire (Press Release) 00:02 Thu, 18 Jun
